Dyadic International (DYAI) Cash & Equivalents (2017 - 2026)
Dyadic International (DYAI) reported Cash & Equivalents of $5.16 million for Q1 2026, up 1.8% from $5.06 million a year earlier but down 11.9% from the prior quarter.
Powered by 
Analysis
Dyadic International (DYAI) Cash & Equivalents (2017 - 2026) Analysis & Trends
At the end of FY2025, Dyadic International posted Cash & Equivalents of $5.85 million, down 10.0% from FY2024.
- Cash & Equivalents has a five-year compound annual growth rate of -22.3% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $6.51 million in FY2024 (-0.1%), $6.52 million in FY2023 (+12.4%), $5.79 million in FY2022 (-63.2%) and $15.75 million in FY2021 (-23.7%).
- Five-year quarterly Cash & Equivalents spans a low of $2.14 million in Q2 2025 and a high of $12.42 billion in Q1 2022.
- Year over year, Cash & Equivalents gained in two of the last eight quarters, with an average decline of 17.8%.
- The high point for year-over-year Cash & Equivalents in five years was Q1 2024 (growth of 65.8%); the low point was Q1 2023 (a decline of 99.9%).
- Per Business Quant data, the three quarters before Q1 2026 came in at $5.85 million (Q4 2025), $5.83 million (Q3 2025) and $2.14 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Dyadic International | 16.76 Mn | 10.16 Mn | - | 5.16 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 5.16 Mn |
| Dec 31, 2025 | 5.85 Mn |
| Sep 30, 2025 | 5.83 Mn |
| Jun 30, 2025 | 2.14 Mn |
| Mar 31, 2025 | 5.06 Mn |
| Dec 31, 2024 | 6.51 Mn |
| Sep 30, 2024 | 5.92 Mn |
| Jun 30, 2024 | 6.13 Mn |
| Mar 31, 2024 | 10.57 Mn |
| Dec 31, 2023 | 6.52 Mn |
| Sep 30, 2023 | 7.40 Mn |
| Jun 30, 2023 | 5.84 Mn |
| Mar 31, 2023 | 6.37 Mn |
| Dec 31, 2022 | 5.79 Mn |
| Sep 30, 2022 | 6.74 Mn |
| Jun 30, 2022 | 9.48 Mn |
| Mar 31, 2022 | 12.42 Bn |
| Dec 31, 2021 | 15.75 Mn |
| Sep 30, 2021 | 13.66 Mn |
| Jun 30, 2021 | 14.02 Mn |
API Access
Dyadic International Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=DYAI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "DYAI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=DYAI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();